|
|
|
|
| LEADER |
03319nam a22003495i 4500 |
| 001 |
000280035 |
| 005 |
20210129083625.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100623s2010 ne | s |||| 0|eng d |
| 020 |
|
|
|a 9789048185535
|
| 024 |
7 |
|
|a 10.1007/978-90-481-8553-5
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Brain Protection in Schizophrenia, Mood and Cognitive Disorders /
|c edited by Michael S. Ritsner.
|
| 250 |
|
|
|a 1st ed. 2010.
|
| 260 |
# |
# |
|a Dordrecht :
|b Springer Netherlands :
|b Imprint: Springer,
|c 2010.
|
| 300 |
|
|
|a XV, 663 p. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Neuroprotective Strategies and Mechanisms -- Brain Protection in Neuropsychiatric Disorders: Past, Present and Future Challenges -- Towards a New Paradigm in Neuroprotection and Neuroplasticity -- What Protects Patients with Schizophrenia from Developing Alzheimer Pathology? -- Assessing In Vivo Neurodegeneration in Schizophrenia Using Magnetic Resonance -- Vulnerability of the Brain to Neuropsychiatric Disorders Resulting from Abnormal Thyroid Hormone or Vitamin D Homeostasis -- Phosphatidylinositol 3-Kinase/Glycogen Synthase Kinase and Mitogen-Activated Protein Kinase Signalling Cascades in Neuronal Cell Survival: What the Neurotrophins Have Taught Us and Implications For Neuropsychiatric Disorders -- One-Compound-Multi-Targets at Amyloid ? Cascade Offered By Bis(7)-Cognitin, a Novel Anti-Alzheimer’s Dimer -- Common Pathways to Neurodegeneration and Co-morbid Depression -- Breakdown of the Blood-Brain Barrier in Stress Alters Cognitive Dysfunction and Induces Brain Pathology: New Perspectives for Neuroprotective Strategies -- Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy -- Carbon Nanotubes as Electrical Interfaces with Neurons -- II. Neuroprotective Treatment and Neuromodulation -- Is a Neuroprotective Therapy Suitable for Schizophrenia Patients? -- Recombinant Human Erythropoietin: Novel Approach to Neuroprotection and Neuroregeneration in Schizophrenia -- Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications -- Neuroprotection in Bipolar Depression -- New Antiepileptic Drugs in Neuropsychiatric Disorders – Basic Mechanisms Related to Clinical Efficacy -- The Neuroprotective Efficacy of Vitamins -- Smoking and Mental Disorders: Focus on Neuroprotection -- Inhibition of Glycine Transporter-1 Improves the Functional Outcome of Schizophrenia -- The Role of Oxytocin in Neuropsychiatric Disorders: Concepts and Mechanisms -- Neuromodulation for Neuropsychiatric Disorders: Novel Techniques -Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation.
|
| 650 |
|
0 |
|a Neurosciences.
|
| 650 |
|
0 |
|a Psychiatry.
|
| 650 |
|
0 |
|a Biological psychology.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
1 |
4 |
|a Neurosciences.
|
| 650 |
2 |
4 |
|a Psychiatry.
|
| 650 |
2 |
4 |
|a Biological Psychology.
|
| 650 |
2 |
4 |
|a Biomedicine, general.
|
| 700 |
1 |
|
|a Ritsner, Michael S.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|